Moradi, A
,
Sepah, Y J
Ibrahim, M A
Sophie, R
Moazez, C
Bittencourt, M G
Annam, R E
Hanout, M
Liu, H
Ferraz, D
Do, D V
Nguyen, Q D
Article History
Received: 13 January 2014
Accepted: 26 June 2014
First Online: 22 August 2014
Competing interests
: Dr Nguyen serves on the Steering Committees for the studies of ranibizumab and aflibercept for retinal vascular diseases sponsored by Genentech and Regeneron. Dr Do serves on the Steering Committee for the studies of aflibercept in diabetic macular oedema sponsored by Regeneron. The READ-2 Study was supported by the Juvenile Diabetes Research Foundation.